Efthymios Deliargyris
Chief Medical Officer, PLx Pharma Winddown Corp.
Companies
- CytosorbentsChief Medical Officer May 5, 2020 to now1
- PLx Pharma Winddown Corp.Chief Medical Officer Aug 31, 2018 to Mar 24, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Cytosorbents CTSO473,025 shares3$2.4M at $4.98Aug 8, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 8, 2025Granted 70,000 shares of Cytosorbents3
- Jan 17, 2025Exercised 16,233 shares at $1.00 of Cytosorbents4
- Apr 2, 2024Granted 61,000 shares of Cytosorbents5
- Dec 13, 2023Bought 22,557 shares at $1.33 of Cytosorbents6
- Jul 7, 2023Granted 55,000 shares of Cytosorbents7
- Aug 10, 2022Granted 52,000 shares of Cytosorbents8
- Aug 10, 2022Granted 55,000 shares of Cytosorbents8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCytosorbents, Chief Medical Officer
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 22, 2025
- 5SEC EDGARForm 4 filed Apr 4, 2024
- 6SEC EDGARForm 4 filed Dec 15, 2023
- 7SEC EDGARForm 4 filed Jul 11, 2023
- 8SEC EDGARForm 4 filed Aug 12, 2022